.STUDY FEATURE.06 August 2024.
A sizable randomized regulated test along with cisgender women highlights the obstacles of obedience to a day-to-day oral preexposure treatment regiment as well as displays that twice-yearly injection of lenacapavir may sustain helpful HIV prevention levels over 6 months.